Outcome measures All primary (behavioral measurements) and secondary outcomes (intracellular glutathione levels and adverse events) were obtained at baseline and study end
The following is the list of possible risks with Lipo-Mino: Redness Pain or bruising Bleeding at the injection site (usually minimal and dissipate in a minimal amount of time) Allergic reaction to the injections Urinary problems (urge incontinence) Diarrhea or upset stomach In addition, B12 has been reported to cause peripheral vascular thrombosis and itching, with some patients experiencing joint pain
It has proven potential for supporting the management of persistent gastrointestinal conditions, similar to inflammatory bowel diseases (IBD), together with ulcerative colitis (UC)
Yes, if used in recommended amounts and followed by sunscreen
This leads to common aging signs like fatigue, weakened immunity, slower healing, and age-related diseases
However, 5 years of follow-up indicated that within that period, after vagotomy, there is a reduced risk of PD, and very similar results were obtained in the 10-year follow-up